NCT02119104View on ClinicalTrials.gov

Prevenar (13v) Infant Drug Use Investigation

CompletedOBSERVATIONAL
Enrollment

1,087

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

May 31, 2016

Study Completion Date

May 31, 2016

Conditions
Infants
Interventions
DRUG

Prevenar (13v)

Prevenar (13v)

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT02119104 - Prevenar (13v) Infant Drug Use Investigation | Biotech Hunter | Biotech Hunter